Kintegral Advisory LLC Has $1.90 Million Stake in Waters Corporation (NYSE:WAT)

Kintegral Advisory LLC lessened its position in shares of Waters Corporation (NYSE:WAT - Free Report) by 32.9% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 5,147 shares of the medical instruments supplier's stock after selling 2,523 shares during the quarter. Kintegral Advisory LLC's holdings in Waters were worth $1,897,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the company. Wealthfront Advisers LLC raised its holdings in shares of Waters by 106,144.4% in the fourth quarter. Wealthfront Advisers LLC now owns 3,087,461 shares of the medical instruments supplier's stock valued at $1,145,386,000 after buying an additional 3,084,555 shares during the last quarter. Norges Bank acquired a new position in Waters in the 4th quarter valued at about $284,415,000. GAMMA Investing LLC raised its stake in Waters by 50,228.3% during the 1st quarter. GAMMA Investing LLC now owns 662,320 shares of the medical instruments supplier's stock valued at $244,111,000 after acquiring an additional 661,004 shares during the last quarter. Millennium Management LLC lifted its position in Waters by 3,349.7% during the 4th quarter. Millennium Management LLC now owns 304,404 shares of the medical instruments supplier's stock worth $112,928,000 after acquiring an additional 295,580 shares during the period. Finally, Madison Investment Advisors LLC purchased a new position in shares of Waters in the 4th quarter valued at approximately $104,645,000. Institutional investors and hedge funds own 94.01% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. KeyCorp raised Waters from a "sector weight" rating to an "overweight" rating and set a $460.00 price target for the company in a report on Monday, March 31st. JPMorgan Chase & Co. raised their target price on shares of Waters from $380.00 to $390.00 and gave the stock a "neutral" rating in a research note on Thursday, March 6th. Baird R W upgraded shares of Waters from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, March 26th. UBS Group reduced their price objective on shares of Waters from $415.00 to $360.00 and set a "neutral" rating for the company in a research report on Wednesday, May 7th. Finally, Wall Street Zen lowered Waters from a "buy" rating to a "hold" rating in a report on Saturday, June 7th. Ten research analysts have rated the stock with a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $388.00.

Waters Stock Down 0.5%

WAT traded down $1.70 on Friday, reaching $350.22. 251,699 shares of the company traded hands, compared to its average volume of 471,262. Waters Corporation has a 52-week low of $279.24 and a 52-week high of $423.56. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.81 and a quick ratio of 1.28. The company has a market cap of $20.84 billion, a price-to-earnings ratio of 31.78, a PEG ratio of 3.46 and a beta of 1.10. The stock's 50 day moving average price is $348.81 and its 200-day moving average price is $364.39.

Waters (NYSE:WAT - Get Free Report) last posted its earnings results on Tuesday, May 6th. The medical instruments supplier reported $2.25 earnings per share for the quarter, beating the consensus estimate of $2.22 by $0.03. Waters had a return on equity of 41.70% and a net margin of 22.02%. The company had revenue of $661.71 million for the quarter, compared to analyst estimates of $655.50 million. During the same period last year, the company earned $2.21 earnings per share. The business's revenue was up 3.9% compared to the same quarter last year. On average, sell-side analysts expect that Waters Corporation will post 12.86 EPS for the current fiscal year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.